Mª Paz
Nombela Blanco
Ikertzailea 2020-2023 tartean
Universidad Autónoma de Madrid
Madrid, EspañaUniversidad Autónoma de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2018
-
Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study)
British Journal of Cancer, Vol. 119, Núm. 9, pp. 1052-1059